Physician profile
Vinny Oommen Samuel
NPI 1649324682
$171,036.15
in general payments reported to CMS, 2019-2025
47 companies · $49K in 2025
The $49K reported for 2025 was more than what 99% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $3,893 · 2021: $4,550 · 2022: $1,765 · 2023: $47K · 2024: $51K · 2025: $49K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $138K · Food and Beverage: $8,325 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $138,020.00 |
| Food and Beverage | $8,324.67 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $150,060.13 | 2020-2025 | Da Vinci Surgical System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14,589.74 | 2019-2025 | Ofev |
| Astrazeneca Pharmaceuticals Lp | $821.37 | 2019-2025 | Airsupra, Breztri, Fasenra |
| Insmed, INC. | $710.01 | 2019-2025 | Arikayce, Brinsupri |
| Glaxosmithkline, LLC. | $699.30 | 2019-2025 | Nucala, Trelegy Ellipta |
| Ethicon INC. | $681.56 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $519.24 | 2019-2024 | Opsumit, Uptravi |
| Bayer Healthcare Pharmaceuticals INC. | $282.74 | 2019-2025 | |
| Pulmonx Corporation | $273.15 | 2019-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Sunovion Pharmaceuticals INC. | $215.05 | 2019-2020 | |
| Shionogi INC | $196.86 | 2020-2024 | Fetroja |
| Amgen INC. | $172.17 | 2022-2025 | Tezspire |
| Regeneron Healthcare Solutions, INC. | $170.12 | 2022-2025 | Dupixent |
| Harmony Biosciences LLC | $147.77 | 2020-2022 | |
| United Therapeutics Corporation | $138.32 | 2020-2025 | Tyvaso, Tyvaso |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $125.60 | 2019-2025 | |
| Abbvie INC. | $120.62 | 2022-2025 | Teflaro |
| Fujifilm Healthcare Americas Corporation | $81.19 | 2023 | Fujifilm |
| Allergan, INC. | $80.87 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $76.57 | 2020-2025 | Winrevair |
| Mylan Specialty L.P. | $72.18 | 2019-2021 | |
| Genentech USA, INC. | $67.44 | 2019-2022 | |
| Inogen, INC. | $63.13 | 2022-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Gilead Sciences, INC. | $62.93 | 2019-2020 | |
| Grifols USA, LLC | $45.64 | 2023-2025 | Prolastin-C Liquid |
| Abiomed | $44.80 | 2024 | Impella |
| Janssen Pharmaceuticals, INC | $44.29 | 2019-2023 | Xarelto |
| Jazz Pharmaceuticals INC. | $41.46 | 2019-2020 | |
| Baxter Healthcare | $39.23 | 2022-2023 | Hillrom - Vest System Model 105 Home Care |
| Sandoz INC. | $38.94 | 2019 | |
| Ambu INC. | $35.04 | 2023-2024 | |
| Ani Pharmaceuticals, INC. | $31.79 | 2025 | Purified Cortrophin Gel |
| Electromed, INC. | $31.27 | 2021-2023 | Smartvest |
| Vapotherm INC | $28.69 | 2022 | |
| Philips North America LLC | $28.48 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.05 | 2022 | |
| Itamar Medical INC | $26.87 | 2025 | Watchpatone |
| Novartis Pharmaceuticals Corporation | $24.84 | 2019 | |
| Covidien Lp | $22.26 | 2020 | |
| Melinta Therapeutics, LLC | $17.02 | 2019 | |
| Nuwellis, INC. | $15.01 | 2020 | |
| Boston Scientific Corporation | $14.08 | 2021 | |
| Veran Medical Technologies, INC. | $13.62 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $13.10 | 2020 | |
| Inari Medical, INC. | $13.09 | 2019 | |
| Pfizer INC. | $11.52 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vinny Samuel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.